Table 6.
Compound concentration | Phagocytosis capacity |
|||
---|---|---|---|---|
trisindoline 1 | trisindoline 3 | trisindoline 4 | doxorubicin | |
0 μg/mL | 1.94 ± 0.01abc | 2.31 ± 0.17b | 1.80 ± 0.30b | 2.31 ± 0.17b |
6.25 μg/mL | 2.73 ± 0.23c | 2.96 ± 0.59b | 1.95 ± 0.18a | 0.41 ± 0.40a |
12.5 μg/mL | 2.52 ± 0.46bc | 1.43 ± 0.13a | 1.99 ± 0,18a | 0.92 ± 0.65a |
25 μg/mL | 1.59 ± 0.24ab | 1.40 ± 0.18a | 2.21 ± 0.39a | 0.37 ± 0.11a |
50 μg/mL | 1.27 ± 0.02a | 1.22 ± 0.57a | 1.92 ± 0.21a | 0.07 ± 0.01a |
Note: Different superscripts in the same column showed significant differences (p < 0.05).